Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD.

guest :: login DZNEPUB
		Search		Submit		Personalize Your alerts Your baskets Your searches		Help

Home > Publications Database > Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD. > Access to Fulltext

Information
Files

Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD. - DZNE-2023-00315

Main document file(s):

Similar records

DZNEPUB :: :: :: ::
Powered by v1.1.7 |
Maintained by

Impressum | Data Privacy Policy